Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate

References

• CushmanWCThe burden of uncontrolled hypertension: morbidity and mortality associated with disease progressionJ Clin Hypertens200351422
   PubMedGoogle Scholar
• MacMahonSPetoRCollinsRBlood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasLancet19903357657741969518
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRfor the Committee at NHB-PEPCThe seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressureJAMA20032892560257112748199
   PubMed Web of Science ®Google Scholar
• RosamondWFlegalKFridayGfor the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2007 updateCirculation2007115e69e17117194875
   PubMed Web of Science ®Google Scholar
• HeidenreichPATrogdonJGKhavjouOAForecasting the future of cardiovascular disease in the United StatesCirculation201112393394421262990
   PubMed Web of Science ®Google Scholar
• PittmanDGTaoZChenWStettinGDAntihypertensive medication adherence and subsequent healthcare utilization and costsAm J Manag Care20101656857620712390
   PubMed Web of Science ®Google Scholar
• OrmondBASpillmanBCWaidmannTACaswellKJTereshchenkoBPotential national and state medical care savings from primary disease preventionAm J Public Health201110115716421088270
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDMEvansJCLevyDHypertension in adults across the age spectrumJAMA200529446647216046653
   PubMed Web of Science ®Google Scholar
• Degli EspostiLValpianiGPharmacoeconomic burden of undertreating hypertensionPharmacoeconomics20042290792815362928
   PubMed Web of Science ®Google Scholar
• DusingROptimizing blood pressure control through the use of fixed combinationsVasc Health Risk Manag2010632132520531950
   PubMedGoogle Scholar
• EfactsFacts and comparisons [website on the Internet] Available from: http://www.efactsweb.com/index.aspAccessed August 15, 2011
   Google Scholar
• HoutzagersJJSmildeJGCreytensGWestergrenGEfficacy and tolerability of a new controlled-release formulation of metoprolol: a comparison with conventional metoprolol tablets in mild to moderate hypertensionEur J Clin Pharmacol198833 SupplS39443371393
   PubMed Web of Science ®Google Scholar
• CarruthersGShearerRTaylorWMooreMA comparison of a controlled release (cr/zok) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertensionJ Clin Pharmacol199030S61S652179282
   PubMed Web of Science ®Google Scholar
• RedbookMontvale, NJThomson Healthcare2011
   Google Scholar
• BaserOToo much ado about propensity score models? Comparing methods of propensity score matchingValue Health2006937738517076868
   PubMed Web of Science ®Google Scholar
• BurnierMMedication adherence and persistence as the cornerstone of effective antihypertensive therapyAm J Hypertens2006191190119617070434
   PubMed Web of Science ®Google Scholar
• SchroederKFaheyTEbrahimSHow can we improve adherence to blood pressure-lowering medication in ambulatory care?: Systematic review of randomized controlled trialsArch Intern Med200416472273215078641
   PubMed Web of Science ®Google Scholar
• AndrejakMGenesNVaurLPonceletPClersonPCarreAElectronic pill-boxes in the evaluation of antihypertensive treatment compliance: Comparison of once daily versus twice daily regimenAm J Hypertens20001318419010701819
   PubMed Web of Science ®Google Scholar
• BairdMGBentley-TaylorMMCarruthersSGA study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (betaloc) in hypertension. Betaloc compliance Canadian cooperative study groupClin Invest Med19847951026380858
   PubMed Web of Science ®Google Scholar
• DetryJMBlockPDe BackerGDegauteJPPatient compliance and therapeutic coverage: Comparison of amlodipine and slow release nifedipine in the treatment of hypertension. The Belgian collaborative study groupEur J Clin Pharmacol1995474774817768247
   PubMed Web of Science ®Google Scholar
• LeenenFHWilsonTWBolliPPatterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: A randomized clinical trial using electronic monitoringCan J Cardiol1997139149209374947
   PubMed Web of Science ®Google Scholar
• GirvinBMcDermottBJJohnstonGDA comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient complianceJ Hypertens1999171627163110608477
   PubMed Web of Science ®Google Scholar
• ChengMMAlfonsoRBestJHGarrisonLPBruhnDVeenstraDLThe economic value of reducing medication dosing frequency with drug delivery technologies: an evidence assessmentJ Med Econ20101319320220334490
   PubMedGoogle Scholar
• SchroederKFaheyTHayADMontgomeryAPetersTJRelationship between medication adherence and blood pressure in primary care: prospective studyJ Hum Hypertens20062062562716543906
   PubMed Web of Science ®Google Scholar
• ZannadFBrianconSJuilliereYIncidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l’Insuffisance Cardiaque Avancée en LorraineJ Am Coll Cardiol19993373474210080475
   PubMed Web of Science ®Google Scholar
• TuWMorrisABLiJAssociation between adherence measurements of metoprolol and health care utilization in older patients with heart failureClin Pharmacol Ther20057718920115735613
   PubMed Web of Science ®Google Scholar
• BraunschweigFCowieMRAuricchioAWhat are the costs of heart failure?Europace201113ii13ii1721518742
   PubMed Web of Science ®Google Scholar
• RuckerNL$4 generics: how low, how broad, and why patient engagement is pricelessJ Am Pharm Assoc (2003)20105076176321071325
   PubMed Web of Science ®Google Scholar
• HodgsonTACaiLMedical care expenditures for hypertension, its complications, and its comorbiditiesMed Care20013959961511404643
   PubMed Web of Science ®Google Scholar
• HodgsonTACohenAJMedical care expenditures for selected circulatory diseases: opportunities for reducing national health expendituresMed Care199937994101210524367
   PubMed Web of Science ®Google Scholar